In the Spotlight-December 2004

The AbYlink technology enables a seamless, reproducible conjugation of payloads to antibodies or ADCs.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.

The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple states.